[1]
L. A, U. H. M, K. B. M, and M. K. P.V, “Marketing Authorization of Generic Drugs and Challenges”, WJPBT, vol. 8, no. 1, pp. 19–27, Jun. 2021, doi: 10.30904/j.wjpbt.2021.4351.